MASIMO CORP - 10 Aug 2023 Form 4 Insider Report for Neuraxis, INC (NRXS)

Role
10%+ Owner
Signature
/s/ Micah Young, Executive Vice President & Chief Financial Officer, Masimo Corporation
Issuer symbol
NRXS
Transactions as of
10 Aug 2023
Transactions value $
$0
Form type
4
Filing time
10 Aug 2023, 17:16:47 UTC
Previous filing
08 Aug 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXS Common Stock Conversion of derivative security +532K 532K 10 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRXS Series A Preferred Stock Conversion of derivative security $0 -266K -100% $0.00* 0 10 Aug 2023 Common Stock 532K Direct F1
transaction NRXS Pre-Funded Warrant, Series A Preferred Stock (Right to Buy) Conversion of derivative security $0 -145K -100% $0.00* 0 10 Aug 2023 Series A Preferred Stock 145K $0.00 Direct F2
transaction NRXS Pre-Funded Warrant, Common Stock (Right to Buy) Conversion of derivative security $0 +290K $0.00 290K 10 Aug 2023 Common Stock 290K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.
F2 The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.